Literature DB >> 11786423

Induction of myocarditis and valvulitis in lewis rats by different epitopes of cardiac myosin and its implications in rheumatic carditis.

Jeffrey E Galvin1, Mark E Hemric, Stanley D Kosanke, Stephen M Factor, Anthony Quinn, Madeleine W Cunningham.   

Abstract

Immune responses against cardiac myosin and group A streptococcal M protein have been implicated in the pathogenesis of rheumatic heart disease. Although cardiac myosin is known to produce myocarditis in susceptible animals, it has never been investigated for its role in production of valvular heart disease, the most serious sequelae of group A streptococcal infection in acute rheumatic fever. In our study, cardiac myosin induced valvulitis in the Lewis rat, and epitopes responsible for production of valvulitis were located in the rod region. Human and rat cardiac myosins induced severe myocarditis in the Lewis rats as expected. A purified S2 fragment (amino acid sequences 842 to 1295) produced the most severe myocarditis as well as valvulitis. Different regions of light meromyosin produced valvulitis (residues 1685 to 1936) or myocarditis (residues 1529 to 1611). Because streptococcal M proteins produced valvular heart disease in Lewis rats and have been linked to anti-cardiac myosin responses, we reacted myosin-sensitized lymphocytes isolated from the hearts of Lewis rats with peptides of streptococcal M5 protein in tritiated thymidine assays. Infiltrating lymphocytes responded most strongly to peptides within the B repeat region of streptococcal M protein. These data show direct evidence that immune responses against cardiac myosin lead to valvular heart disease and the infiltration of the heart by streptococcal M protein reactive T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786423      PMCID: PMC1867128          DOI: 10.1016/S0002-9440(10)64373-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

1.  T-Cell-dependent antibody response to the dominant epitope of streptococcal polysaccharide, N-acetyl-glucosamine, is cross-reactive with cardiac myosin.

Authors:  S Malkiel; L Liao; M W Cunningham; B Diamond
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Myosin: a link between streptococci and heart.

Authors:  K Krisher; M W Cunningham
Journal:  Science       Date:  1985-01-25       Impact factor: 47.728

3.  A study of anti-group A streptococcal monoclonal antibodies cross-reactive with myosin.

Authors:  M W Cunningham; N K Hall; K K Krisher; A M Spanier
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

4.  Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin.

Authors:  J E Galvin; M E Hemric; K Ward; M W Cunningham
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

5.  Preparation of myosin and its subfragments from rabbit skeletal muscle.

Authors:  S S Margossian; S Lowey
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

6.  Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis.

Authors:  N Neu; K W Beisel; M D Traystman; N R Rose; S W Craig
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

7.  Induction of autoimmune valvular heart disease by recombinant streptococcal m protein.

Authors:  A Quinn; S Kosanke; V A Fischetti; S M Factor; M W Cunningham
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

8.  Cardiac myosin induces myocarditis in genetically predisposed mice.

Authors:  N Neu; N R Rose; K W Beisel; A Herskowitz; G Gurri-Glass; S W Craig
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

9.  Enzymatic comparisons between light chain isozymes of human cardiac myosin subfragment-1.

Authors:  L S Tobacman; R S Adelstein
Journal:  J Biol Chem       Date:  1984-09-25       Impact factor: 5.157

10.  Polyspecificity of antistreptococcal murine monoclonal antibodies and their implications in autoimmunity.

Authors:  M W Cunningham; R A Swerlick
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  29 in total

1.  Anticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients.

Authors:  Safa Kalache; Rajani Dinavahi; Sean Pinney; Anita Mehrotra; Madeleine W Cunningham; Peter S Heeger
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

Review 2.  Role of impaired central tolerance to α-myosin in inflammatory heart disease.

Authors:  HuiJuan Lv; Myra A Lipes
Journal:  Trends Cardiovasc Med       Date:  2012-08-16       Impact factor: 6.677

Review 3.  The clinical and diagnostic significance of anti-myosin autoantibodies in cardiac disease.

Authors:  Udi Nussinovitch; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

Review 4.  Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae.

Authors:  Madeleine W Cunningham
Journal:  Microbiol Spectr       Date:  2019-07

5.  An animal model of chronic rheumatic valvulitis induced by formalin-killed streptococci.

Authors:  Xujing Xie; Hanjian Zhou; Jianlin Huang; Huanlei Huang; Zhiying Feng; Kaiyong Mei; Buyun Yu; Zulan Su; Jieruo Gu
Journal:  Rheumatol Int       Date:  2009-12-12       Impact factor: 2.631

6.  Repeat exposure to group A streptococcal M protein exacerbates cardiac damage in a rat model of rheumatic heart disease.

Authors:  Davina Gorton; Suchandan Sikder; Natasha L Williams; Lisa Chilton; Catherine M Rush; Brenda L Govan; Madeleine W Cunningham; Natkunam Ketheesan
Journal:  Autoimmunity       Date:  2016-08-25       Impact factor: 2.815

7.  Rheumatic heart disease: 15 years of clinical and immunological follow-up.

Authors:  Roney O Sampaio; Kellen C Fae; Lea M F Demarchi; Pablo M A Pomerantzeff; Vera D Aiello; Guilherme S Spina; Ana C Tanaka; Sandra E Oshiro; Max Grinberg; Jorge Kalil; Luiza Guilherme
Journal:  Vasc Health Risk Manag       Date:  2007

Review 8.  Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy.

Authors:  Jason M Lappé; Clara M Pelfrey; W H Wilson Tang
Journal:  J Card Fail       Date:  2008-05-27       Impact factor: 5.712

9.  Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies.

Authors:  Adita Mascaro-Blanco; Kathy Alvarez; Xichun Yu; JoAnn Lindenfeld; Leann Olansky; Timothy Lyons; David Duvall; Janet S Heuser; Albina Gosmanova; Carl J Rubenstein; Leslie T Cooper; David C Kem; Madeleine W Cunningham
Journal:  Autoimmunity       Date:  2008-09       Impact factor: 2.815

10.  B- and T-cell responses in group a streptococcus M-protein- or Peptide-induced experimental carditis.

Authors:  Davina Gorton; Brenda Govan; Colleen Olive; Natkunam Ketheesan
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.